🎧 FREE MSRA PODCAST – Placenta Accreta: When the Placenta Won’t Let Go

A silent threat with life-changing consequences—placenta accreta is one of the most important (and rising) emergencies in modern obstetrics. We break down the core facts you need for the MSRA, using UK NICE guidelines and high-yield revision insights.

📝 Key Learning Points

📌 Definition & Types
• Placenta accreta = placenta attaches abnormally deep into the uterine wall
• Accreta: villi attached to the myometrium
• Increta: villi invade into the muscle
• Percreta: villi invade through the myometrium, may involve bladder/bowel
• Makes separation at delivery very difficult—risk of massive bleeding

📌 Causes & Risk Factors
• Biggest risk: previous Caesarean section (C-section)
 – Risk rises dramatically with each additional C-section (e.g. 1 prev CS ≈ 0.3%, 5 prev CS ≈ 7%)
• Placenta previa, prior uterine surgery, multiparity, advanced maternal age
• More C-sections globally = higher accreta rates

📌 Symptoms
• Often asymptomatic during pregnancy
• Possible sign: painless vaginal bleeding (usually third trimester or at delivery)
• May be suspected if uterus larger than expected, or abnormal fetal heart rate

📌 Diagnosis (UK Pathway)
• Antenatal imaging is vital in high-risk women
 – Ultrasound (first line for placental location and depth of invasion)
 – MRI (if US inconclusive or deep invasion suspected—especially for surgical planning)

📌 Management
• Always multidisciplinary—obstetricians, anaesthetists, haematologists, surgeons
• Planned elective Caesarean hysterectomy (deliver baby, then remove uterus with placenta in situ)
• Blood products ready—high risk of major haemorrhage
• Specialist centre with ICU, experienced pelvic surgeons
• Conservative management (placenta left in situ) possible but risky—consider only if fertility preservation is critical

📌 Complications
• Severe postpartum haemorrhage (PPH)—main immediate threat
• Need for emergency hysterectomy
• Injury to bladder/bowel (especially with percreta)
• Infection (esp. with conservative management)
• Maternal morbidity/mortality

📌 Prognosis
• Depends on depth of invasion, planning, and centre expertise
• Early diagnosis & team-based care improve outcomes
• Still a leading cause of major obstetric haemorrhage

📎 More Placenta Accreta Revision Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/placenta-accreta-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/placenta-accreta-flashcards/
💬 Accordion Q&A: https://www.passthemsra.com/topic/placenta-accreta-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/placenta-accreta-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/placenta-accreta/
🎓 Full Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

#MSRA #PlacentaAccreta #MSRARevision #Obstetrics #PassTheMSRA #HighYield #ExamRevision #UKGuidelines #ObstetricsAndGynaecology #MaternalHealth

⚕️ FREE MSRA PODCAST – Pelvic Inflammatory Disease (PID)
🎧 A deep, high-yield breakdown of this common but serious infection affecting young women – vital for both exam prep and real-world GP practice!

🧠 Key Learning Points

📌 Definition
• Infection of the upper female genital tract (uterus, tubes, ovaries)
• Usually caused by ascending spread of sexually transmitted or vaginal bacteria

📌 Causes & Risk Factors
• STIs: Chlamydia trachomatis, Neisseria gonorrhoeae
• Mycoplasma, anaerobes, normal vaginal flora
• Risk ↑ with:
 • Age <25
 • Multiple sexual partners
 • Unprotected sex
 • Previous STI
 • IUD insertion (esp. within 20 days)
 • Douching

📌 Pathophysiology
• Bacteria ascend → trigger inflammation → damage to reproductive organs
• Leads to scarring, adhesions, chronic pain, and potential infertility

📌 Symptoms
• Bilateral lower abdominal pain
• Abnormal or purulent vaginal discharge
• Fever >38°C
• Dyspareunia (painful sex)
• Intermenstrual or postcoital bleeding
• Urinary symptoms, nausea, vomiting
• Can be asymptomatic!

📌 Differential Diagnosis
• 🚨 Ectopic pregnancy (do pregnancy test!)
• Appendicitis
• Endometriosis
• UTI
• Ovarian cyst/torsion
• Retained foreign body (e.g. tampon)

📌 Diagnosis
• Clinical suspicion + key signs:
 • Cervical motion tenderness
 • Adnexal tenderness
• Do pregnancy test first
• Cervical swabs (NAATs for chlamydia/gonorrhoea)
• Consider CRP/ESR, urine dip, ultrasound if needed
• Imaging may help rule out abscess or other causes

📌 Management
💊 Start antibiotics immediately – don’t wait for results!
• Broad-spectrum cover: ceftriaxone + doxycycline + metronidazole
• Provide analgesia
🏥 Admit if:
 • Severe symptoms
 • Suspected abscess
 • Pregnancy
 • Unable to take oral meds
🔁 Review at 72 hours

📌 Partner Notification
• Test & treat sexual partners
• Avoid sex until both partners complete treatment
• Contact trace last 60 days

📌 Complications
❌ Infertility (risk 10–20% after one episode!)
❌ Chronic pelvic pain
❌ Ectopic pregnancy
❌ Tubo-ovarian abscess
❌ Fitz-Hugh Curtis syndrome (RUQ pain)
❌ Adverse pregnancy outcomes

📌 Prognosis
• Good with prompt treatment
• Delays ↑ risk of long-term harm

📎 More MSRA Resources for Pelvic Inflammatory Disease

📝 Revision Notes
https://www.passthemsra.com/topic/pelvic-inflammatory-disease-revision-notes/

🧠 Flashcards
https://www.passthemsra.com/topic/pelvic-inflammatory-disease-flashcards/

💬 Accordion Q&A Notes
https://www.passthemsra.com/topic/pelvic-inflammatory-disease-accordion-qa-notes/

🚀 Rapid Quiz
https://www.passthemsra.com/topic/pelvic-inflammatory-disease-rapid-quiz/

🧪 Quiz Page
https://www.passthemsra.com/quizzes/pelvic-inflammatory-disease/

🎓 Full Course – Obstetrics & Gynaecology for the MSRA
https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

📢 Final Takeaway
Low threshold for treatment is key. Acting early prevents lifelong issues like infertility and ectopic pregnancy. Always rule out ectopic and treat partners. Know those high-yield signs!

#MSRA #PelvicInflammatoryDisease #PID #MSRARevision #MSRAFlashcards #MSRAQuestionBank #MSRAQuiz #GPTraining #SexualHealth #ReproductiveHealth #MSRAOnlineRevision #PassTheMSRA

⚕️ FREE MSRA PODCAST – Ovarian Hyperstimulation Syndrome (OHSS)
🎧 A clear, high-yield breakdown of this IVF-related complication with systemic impact – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• An iatrogenic complication of fertility treatments (e.g. IVF)
• Caused by an exaggerated ovarian response to stimulation, leading to enlarged ovaries and third-space fluid shifts

📌 Causes & Risk Factors
• Gonadotropin stimulation (e.g. FSH)
• HCG trigger shot (especially high doses)
• Risk factors:
 – Age <30
 – PCOS
 – High AMH or follicle count
 – Low BMI
 – Previous OHSS
 – Use of HCG for luteal support
💡 Mnemonic: "OHSS RISK" – Ovarian Reserve ↑, IVF meds, Stimulation high-dose, KGs low (low BMI)

📌 Pathophysiology
• Follicle stimulation → ↑ VEGF release
• VEGF → ↑ vascular permeability
• Leads to fluid leakage into abdomen (ascites), pleura (effusions), and pericardium
• Causes hemoconcentration, hypovolaemia, and clot risk

📌 Symptoms
• Mild: Bloating, nausea, enlarged ovaries <8cm
• Moderate: Pain, ascites, ovaries 8–12cm
• Severe: Tense ascites, oliguria, SOB, hemoconcentration, ovaries >12cm
• Critical: HCT >55%, WCC >25, ARDS, thromboembolism, renal failure
💡 Mnemonic: "BLOOD CLOTS" – Bloating, Lungs (SOB), Oliguria, Ovaries ↑, Distension, Clots, Leaky capillaries, Overload risk, Thick blood, Shock

📌 Differential Diagnosis
• Ovarian torsion
• Ruptured ovarian cyst
• Ectopic pregnancy
• Acute abdomen (non-gynae causes)

📌 Diagnosis
• Ultrasound: Enlarged ovaries, ascites
• Bloods:
 – FBC (HCT ↑, WCC ↑)
 – U&Es, creatinine (renal)
 – LFTs
 – Coagulation screen
• Chest X-ray (pleural effusion)
• Daily abdominal girth for monitoring

📌 Management
🩺 Mild (outpatient):
• Oral hydration
• Paracetamol for pain
• Education re: red flags

🏥 Moderate/Severe (inpatient):
• IV fluids (judiciously)
• Monitor: obs, input/output, daily weight/girth
• Avoid: NSAIDs, diuretics
• Thromboprophylaxis: LMWH
• Paracentesis/thoracentesis if symptomatic
• HDU/ICU for critical cases

💡 Prevention:
• Adjust stim dose
• Withhold HCG trigger if high risk
• Freeze-all approach
• “Coasting” (pause stim meds pre-trigger)

📌 Complications
• Thromboembolism (DVT/PE)
• ARDS
• Renal failure
• Ovarian torsion
• Stroke (rare)
• Death (very rare)

📌 Prognosis
• Most cases resolve with supportive care
• Pregnancy may prolong OHSS but does not worsen long-term outcomes

📎 More MSRA Resources for Ovarian Hyperstimulation Syndrome
📝 Revision Notes:
https://www.passthemsra.com/topic/ovarian-hyperstimulation-syndrome-revision-notes/
🧠 Flashcards:
https://www.passthemsra.com/topic/ovarian-hyperstimulation-syndrome-flashcards/
💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/ovarian-hyperstimulation-syndrome-accordion-qa-notes/
🚀 Rapid Quiz:
https://www.passthemsra.com/topic/ovarian-hyperstimulation-syndrome-rapid-quiz/
🎯 Quiz:
https://www.passthemsra.com/quizzes/ovarian-hyperstimulation-syndrome/
🎓 Full Course:
https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQandANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #OvarianHyperstimulationSyndrome #ObstetricsAndGynaecology

⚕️ FREE MSRA PODCAST – Ovarian Enlargement
🎧 A clear, high-yield breakdown of this common pelvic finding – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Ovarian enlargement refers to abnormal increase in ovarian size
• It’s a sign, not a disease – think of it like fever: a clue to an underlying issue

📌 Causes & Risk Factors
• Functional cysts (e.g. follicular, corpus luteum)
• Benign or malignant ovarian tumours
• Polycystic ovary syndrome (PCOS)
• Ovarian hyperstimulation syndrome (OHSS)
• Endometriosis, infections (PID), torsion
• Risk Factors: Hormonal imbalances, family history, insulin resistance, obesity (esp. for PCOS)
🧠 Mnemonic: C-THIRST
(Cyst, Tumour, Hormones, Infection, Rupture, Stimulation (OHSS), Torsion)

📌 Pathophysiology
• Cysts: Fluid buildup from follicular disruption
• Tumours: Abnormal cell proliferation
• PCOS: Arrested follicular development, hormone imbalance
• OHSS: Fertility drug-induced overstimulation
• Torsion: Ovary twists, causing swelling from compromised blood flow

📌 Symptoms
• Pelvic/abdominal pain or discomfort
• Bloating or increased girth
• Urinary/bowel pressure symptoms
• Menstrual irregularities
• Often asymptomatic and picked up on scan

📌 Differential Diagnosis
• Fibroids
• Pelvic inflammatory disease (PID)
• Tubo-ovarian abscess
• Ovarian torsion (also a cause!)
• Ruptured cysts
• Bowel or urinary pathologies

📌 Diagnosis
• Pelvic ultrasound – 1st line to assess size & cyst features
• Bloods – incl. hormone levels, CA-125 (non-specific tumour marker)
• Further imaging – MRI/CT if unclear
• Biopsy or surgical exploration if malignancy suspected
💡 Mnemonic for investigations: “USS-BIOM”
(Ultrasound, Scan, Surgery, Bloods, Imaging, Ovarian Markers)

📌 Management
• Tailored to underlying cause
• Watchful waiting – for small, simple cysts in premenopausal women
• Medical treatment – for hormonal causes or infections
• Surgical – for large, suspicious, or symptomatic lesions
• Referral for any cyst in postmenopausal women (↑ risk of malignancy)
🔑 Age is key: Under 35 = monitor; Postmenopausal = refer

📌 Complications
• Ovarian torsion
• Cyst/tumour rupture → haemorrhage
• Infertility
• Malignancy
• OHSS from fertility treatment

📌 Prognosis
• Depends on underlying cause
• Benign causes (like functional cysts) = excellent outlook
• Malignancy = poorer prognosis, especially if diagnosis is delayed

📎 More MSRA Resources for Ovarian Enlargement
📝 Revision Notes: https://www.passthemsra.com/topic/ovarian-enlargement-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/ovarian-enlargement-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/ovarian-enlargement-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/ovarian-enlargement-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

📲 Use this deep dive to solidify your understanding and ace questions on ovarian pathology. Remember: if it’s vague or silent, stay alert for red flags like torsion or malignancy. Ovarian enlargement might look subtle but can be clinically significant. 💡

🔖 Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #OvarianEnlargement

🎧 FREE MSRA PODCAST – Ovarian Cyst: High-Yield Deep Dive
This episode is a full walkthrough of everything you need to know about ovarian cysts, pulled straight from detailed MSRA revision notes. From identifying benign cysts like dermoids to recognising red-flag features on ultrasound and deciding when to operate — this is a must-listen if you're revising Obs & Gynae for the MSRA.

🧠 Key Learning Points

📌 Definition
• Ovarian cysts = fluid-filled sacs on/in an ovary
• Often benign, frequently asymptomatic
• Common in reproductive years, rarer postmenopause

📌 Types of Benign Cysts
• Functional (physiological):

• Follicular cysts: failure to ovulate

• Corpus luteum cysts: post-ovulation, fluid-filled
  • Dermoid cysts (mature cystic teratomas):

• Contain hair, teeth, skin

• High risk of torsion
  • Epithelial tumours:

• Serous cystadenoma: can mimic malignancy on scan

• Mucinous cystadenoma: can lead to pseudomyxoma peritonei
  • Endometriomas (chocolate cysts): from endometriosis
  • Theca lutein cysts: linked to high HCG levels
  • Tubo-ovarian abscesses: from pelvic infections
  • PCOS: numerous small cysts + hormonal imbalance

📌 Postmenopausal Considerations
• Cancer risk is much higher
• Complex cysts + ascites = high suspicion
• Simple cysts still often monitored closely

📌 Risk Factors
🔺 BRCA1, BRCA2, Lynch Syndrome
🔺 Endometriosis, infertility, IUD use
✅ Protective: COCP use, breastfeeding >12 months, tubal ligation, previous pregnancy

📌 Pathophysiology
• Disruption of ovulation or abnormal tissue proliferation
• Cysts may twist, rupture, or grow, leading to complications

📌 Differential Diagnoses
🩺 Gynae causes:

• Ectopic pregnancy

• Fibroids, PID, ovarian cancer, PCOS
  🩺 Non-gynae:

• Appendicitis, diverticulitis, bowel cancer, pelvic kidney, lymphoma

📌 Epidemiology
• Most common in reproductive-age women
• Up to 20% of women have incidental cysts
• Malignancy rises sharply postmenopause

📌 Clinical Features
• Often asymptomatic
• If present:

• Pelvic pain (dull, one-sided)

• Abdominal bloating/distension

• Sudden acute pain = torsion/rupture

• Vaginal bleeding (less common)
  • Not typically associated with menstrual cramps or cycle changes

📌 Investigations
🧪 Pelvic Ultrasound (TVUS):
• Benign: Anechoic (black), thin-walled, unilocular
• Suspicious:

• Solid areas

• Thick septations

• Doppler flow

• Ascites
  🧪 Blood Tests:
  • β-hCG – rule out pregnancy
  • CA-125 – cancer marker, but ↑ in many benign conditions
  • Other tumour markers: AFP, LDH, HCG (germ cell), CEA, CA19-9

⚠️ Avoid aspiration in postmenopausal women
• Risk of malignant cell seeding
• Cytology not reliable for excluding cancer

📌 Management
🩺 Expectant Management
• For simple cysts <5cm, especially in young, asymptomatic women
• Monitor with repeat scan in 6–8 weeks

💊 Medical
• COCP – reduce recurrence
• Analgesia for symptom control

🔪 Surgical
• Cystectomy – remove cyst, preserve ovary
• Oophorectomy – if cancer risk high
• Emergency laparoscopy for torsion/rupture with bleeding
• Cyst removal if:

• Large

• Persistent

• Suspicious on scan

• Causing infertility

📌 Complications
• Ovarian torsion – sudden pain, emergency
• Cyst rupture – internal bleeding
• Infection
• Malignancy (especially postmenopause)

📌 Prognosis
• Most cysts resolve spontaneously
• Malignant transformation is rare but serious
• Early diagnosis = better outcomes

📎 More MSRA Resources on Ovarian Cyst
📝 Revision Notes: https://www.passthemsra.com/topic/ovarian-cyst-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/ovarian-cyst-flashcards/
💬 Accordion Q&A: https://www.passthemsra.com/topic/ovarian-cyst-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/ovarian-cyst-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/
#MSRA #OvarianCyst #MSRARevisionNotes #MSRAQuiz #MSRAFlashcards #OvarianTorsion #ObsAndGynae #BRCA #UltrasoundFindings #MSRATextbook #MultiSpecialtyRecruitmentAssessment

🎧 FREE MSRA PODCAST – Ovarian Cancer: From Vague Symptoms to Vital Signs

Facing vague symptoms? Ovarian cancer is the leading cause of gynae cancer deaths in the UK – but early recognition changes everything. This deep dive gives you the absolute high-yield facts and essential UK NICE exam insights to boost your MSRA revision and clinical confidence.

📝 Key Learning Points

📌 Definition & Types
• Ovarian cancer = malignant tumour of the ovary, often epithelial (90% – mainly serous type), but also includes germ cell & sex cord-stromal tumours
• Most common after menopause; high-grade serous carcinoma = most aggressive

📌 Causes & Risk Factors
• Genetics: BRCA1/2 mutations, Lynch syndrome
• Family history of ovarian/breast/colorectal cancer
• Reproductive factors: early menarche, late menopause, nulliparity, infertility
• Others: age >50, HRT, endometriosis, obesity, smoking
• Protective: pregnancy, breastfeeding, OCP use, tubal ligation, hysterectomy

📌 Symptoms
• Often vague & non-specific:
 – Bloating
 – Pelvic/abdominal pain
 – Early satiety
 – Urinary frequency/urgency
• Red flag: persistent or frequent symptoms, especially in women >50
• Late features: ascites, weight loss, abnormal bleeding, pleural effusion, bowel obstruction

📌 Investigations & Diagnosis (UK Pathway)
• Primary care:
 – CA-125 blood test (≥35 IU/mL triggers further investigation)
 – Urgent pelvic ultrasound if CA-125 raised
• Secondary care:
 – CT abdomen/pelvis, chest
 – Risk of Malignancy Index (RMI): >250 (NICE) = MDT referral
 – AFP & β-hCG for germ cell tumours in women <40
• Definitive: biopsy at surgery/laparoscopy
• No population screening available

📌 Management
• MDT approach:
 – Surgery (debulking, staging, oophorectomy, hysterectomy, omentectomy, lymph nodes)
 – Platinum-based chemotherapy (carboplatin + paclitaxel)
 – Targeted therapies: PARP inhibitors (BRCA+), bevacizumab (anti-VEGF)
• Follow-up: CA-125 for monitoring, regular imaging
• Genetic counselling for all diagnosed patients

📌 Complications
• Tumour-related: torsion, rupture, infection
• Advanced disease: bowel obstruction, ascites, pleural effusion, malnutrition, infection
• Treatment-related: bone marrow suppression, neuropathy, nephrotoxicity, ototoxicity
• Recurrence common (75% relapse rate), palliative care often needed

📌 Prognosis
• Stage at diagnosis is key
 – Stage 1: >90% 5-year survival
 – Overall: ~46% 5-year survival (due to 80% presenting at advanced stages)
• Mortality falling in the UK – early recognition saves lives

📎 More Ovarian Cancer Revision Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/ovarian-cancer-revision-notes/
💬 Accordion Q&A: https://www.passthemsra.com/topic/ovarian-cancer-accordion-qa-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/ovarian-cancer-flashcards/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/ovarian-cancer-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/ovarian-cancer/
🎓 Full Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

#MSRA #OvarianCancer #MSRARevision #GynaeOncology #PassTheMSRA #HighYield #ExamRevision #UKGuidelines #Gynaecology #ObstetricsAndGynaecology

⚕️ FREE MSRA PODCAST – Mittelschmerz
🎧 A focused, high-yield guide to this common ovulation-related pelvic pain – perfect for the MSRA, GP training, and clinical insight!

🧠 Key Learning Points

📌 Definition
• Mittelschmerz = “middle pain” (German)
• Ovulation-related lower abdominal pain, typically mid-cycle

📌 Causes & Risk Factors
• Rupture of ovarian follicle releases fluid/blood
• Irritation of the peritoneum triggers pain
• Risk ↑ with:
 • Regular ovulation
 • Past episodes
 • Hormonal imbalance

📌 Pathophysiology
• Follicle bursts → fluid/blood leaks → local inflammation
• Pain = mechanical + chemical irritation of peritoneum

📌 Symptoms
• Unilateral lower abdominal pain
• Mid-cycle (around day 14 in a 28-day cycle)
• Duration: a few minutes to 1–2 days
• Mild vaginal spotting possible
• Can alternate sides month-to-month

📌 Differential Diagnosis
🔍 Always consider:
• Ovarian cyst
• Pelvic Inflammatory Disease (PID)
• Endometriosis
• UTI
• Appendicitis
• GI causes

📌 Diagnosis
• Clinical history = cornerstone
• Physical exam typically normal
• No imaging/labs unless red flags or atypical presentation

📌 Management
🩺 Conservative in most cases:
• Reassurance + patient education
• Analgesia: paracetamol or NSAIDs
• Heat pads + rest
• Hormonal contraception for prevention in recurrent or severe cases

📌 Complications
✅ Benign condition
❌ No long-term complications
• Only investigate if symptoms are atypical or severe

📌 Prognosis
• Excellent
• Self-limiting with no adverse outcomes

📎 More MSRA Resources for Mittelschmerz

📝 Revision Notes
https://www.passthemsra.com/topic/mittelschmerz-revision-notes/

🧠 Flashcards
https://www.passthemsra.com/topic/mittelschmerz-flashcards/

💬 Accordion Q&A Notes
https://www.passthemsra.com/topic/mittelschmerz-accordion-qa-notes/

🚀 Rapid Quiz
https://www.passthemsra.com/topic/mittelschmerz-rapid-quiz/

🧪 Quiz Page
https://www.passthemsra.com/quizzes/mittelschmerz/

🎓 Full Course – Obstetrics & Gynaecology for the MSRA
https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

🎯 Fast Facts to Lock In
• Mid-cycle unilateral pain = think Mittelschmerz
• Clinical diagnosis – history is everything
• No investigations unless red flags
• Treat with analgesia ± hormonal contraceptives if recurrent

#MSRA #Mittelschmerz #MSRAFlashcards #MSRARevision #MSRAQuiz #MSRAQANotes #PassTheMSRA #GPTraining #PelvicPain #OvulationPain #ObstetricsAndGynaecology #MedicalPodcast #FreeMSRA

⚕️ FREE MSRA PODCAST – Menopause
🎧 A clear, high-yield breakdown of this natural midlife reproductive transition – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Permanent cessation of menstruation for 12 consecutive months
• Typically occurs between ages 45–55
• Caused by natural depletion of ovarian follicles and estrogen decline

📌 Causes & Risk Factors
• Age-related ovarian follicle loss
• Genetics (e.g. family history)
• Smoking 🚬
• Autoimmune conditions (e.g. thyroid)
• Surgery (e.g. oophorectomy)
• Chemotherapy/radiotherapy
💡 Mnemonic: “GO SAC” – Genetics, Oophorectomy, Smoking, Autoimmune, Chemo

📌 Pathophysiology
• Fewer ovarian follicles → ↓ estrogen & progesterone
• ↓ Estrogen → disrupted hypothalamic-pituitary feedback
• Leads to amenorrhoea, vasomotor instability, bone & mood changes

📌 Symptoms
• Hot flushes, night sweats
• Menstrual irregularity
• Vaginal dryness, dyspareunia
• Sleep issues, mood swings, brain fog
• ↓ Libido, hair thinning, brittle nails
💡 Mnemonic: “HAVOC” – Hot flushes, Atrophy (vaginal), Vaginal dryness, Osteoporosis, Cognitive/mood change

📌 Differential Diagnosis
• Pregnancy – always rule out first
• Hypothalamic-pituitary disorders
• Thyroid dysfunction
• Medication effects (e.g. hormonal contraception)

📌 Diagnosis
• Clinical in most women >45 with typical symptoms
• No routine labs needed
• FSH helpful only:
 – Ages 40–45 with symptoms
 – On hormonal contraception
 – Suspected POI (<40)
❌ Don’t test LH, estradiol, AMH, inhibin, or do AFC routinely

📌 Management
🩺 Lifestyle:
• Quit smoking 🚭, reduce alcohol 🍷
• Weight control, regular exercise 🏃‍♀️
• Adequate calcium & vitamin D
• Reduce caffeine/spicy food
• Cooling techniques, CBT for mood

💊 Pharmacological:
• HRT (oral/transdermal/topical) → best for vasomotor & urogenital symptoms
• Vaginal estrogen for dryness
• Non-HRT: SSRIs/SNRIs, gabapentin, clonidine
• Lubricants & moisturisers for vaginal symptoms
• Testosterone under specialist guidance for low libido
💡 Higher-dose HRT for early menopause or POI

📌 Complications
• Osteoporosis → fracture risk
• Cardiovascular disease
• Urogenital atrophy
• Mood disorders
• Cognitive decline (research ongoing)

📌 Prognosis
• Symptoms usually resolve over time
• Long-term health risks need proactive screening and care

📎 More MSRA Resources for Menopause
📝 Revision Notes:
https://www.passthemsra.com/topic/menopause-revision-notes/
🧠 Flashcards:
https://www.passthemsra.com/topic/menopause-flashcards/
💬 Accordion Q&A Notes:
https://www.passthemsra.com/topic/menopause-accordion-qa-notes/
🚀 Rapid Quiz:
https://www.passthemsra.com/topic/menopause-rapid-quiz/
🎯 Quiz:
https://www.passthemsra.com/quizzes/menopause/
🎓 Full Course:
https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

#MSRA #MSRARevisionNotes #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQandANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #Menopause #ObstetricsAndGynaecology

⚕️ FREE MSRA PODCAST – Mammary Paget’s Disease
🎧 A clear, high-yield breakdown of this rare nipple-involved breast cancer – perfect for exam prep and clinical awareness.

🧠 Key Learning Points

📌 Definition
• Rare form of breast cancer involving the nipple and areola
• Characterised by malignant Paget cells in the skin
• Strongly associated with underlying DCIS or invasive carcinoma

📌 Causes & Risk Factors
• Unknown exact cause, but often due to migration of cancer cells from DCIS
• Advanced age (>50)
• Female sex (but can occur in men)
• Family history of breast cancer
• BRCA1/BRCA2 mutations
• Previous breast cancer or surgery
💡 Mnemonic: “FAM-BP” = Female, Age, Mutation, Breast cancer hx, Prior surgery

📌 Pathophysiology
• Paget cells infiltrate the epidermis of nipple/areola
• Often originate from deeper ductal malignancy
• Replace normal epithelium causing surface changes

📌 Symptoms
• Eczema-like changes to nipple: scaling, redness, crusting
• Itching, burning, ulceration
• Nipple inversion or discharge (possibly bloody)
• Possible palpable lump → suggests invasive cancer
🎯 Mnemonic: “SCRUB-IN” = Scaling, Crust, Redness, Ulcer, Bloody discharge, Inversion, Nodule

📌 Differential Diagnosis
• Eczema
• Psoriasis
• Nipple adenoma
• Melanoma
🎯 Always rule out Paget’s first if “eczema” on nipple persists

📌 Diagnosis
• Skin biopsy (to detect Paget cells)
• Mammography and/or MRI (to detect DCIS or invasive cancer)
• Core biopsy if a lump is palpable

📌 Management
• Surgery is mainstay (mastectomy or breast-conserving surgery)
• Radiotherapy often added post-op
• Hormonal therapy (if ER+ cancer)
• Chemotherapy if invasive or high risk
📌 NICE supports conservative surgery in selected cases

📌 Complications
• Progression to invasive cancer
• Local recurrence or metastasis
• Diagnostic delays → worse outcomes
• Psychological impact post-treatment

📌 Prognosis
• Best with early DCIS-only cases
• Worse if associated with invasive cancer
• Five-year survival: ~80% for DCIS, ~30% in men
🧠 Diagnostic delay is common and harms outcomes

📎 More MSRA Resources for Mammary Paget’s Disease
📝 Revision Notes: https://www.passthemsra.com/topic/mammary-pagets-disease-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/mammary-pagets-disease-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/mammary-pagets-disease-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/mammary-pagets-disease-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

🔖 Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQ&ANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #MammaryPagetsDisease

⚕️ FREE MSRA PODCAST – Menorrhagia / Heavy Menstrual Bleeding
🎧 In this high-yield episode, we unpack detailed revision notes on menorrhagia. From causes and clinical features to NICE-endorsed investigation and treatment pathways – we’ve got everything you need to know.

🧠 Key Learning Points

📌 Definition
• Menorrhagia = excessive menstrual bleeding that impacts quality of life
• No longer just defined by >80ml blood loss – subjective impact is key
• NICE: bleeding that disrupts physical, emotional, social, or quality of life

📌 Causes
🔹 Dysfunctional Uterine Bleeding (DUB) – most common, esp. with anovulatory cycles in adolescence/perimenopause
🔹 Uterine causes – fibroids, polyps, adenomyosis, endometritis, endometrial hyperplasia or cancer
🔹 Systemic causes – hypothyroidism, bleeding disorders (e.g., von Willebrand disease), liver/kidney disease, obesity
🔹 Iatrogenic causes – IUCD, anticoagulants, hormonal therapy
💡 Mnemonic: PALM-COEIN
(P) Polyps
(A) Adenomyosis
(L) Leiomyoma
(M) Malignancy/hyperplasia
(C) Coagulopathy
(O) Ovulatory dysfunction
(E) Endometrial causes
(I) Iatrogenic
(N) Not classified

📌 Risk Factors
• Age extremes – adolescence & perimenopause
• Family history of menorrhagia
• PCOS, endometriosis
• Use of anticoagulants
• Obesity, endocrine disorders

📌 Pathophysiology
• Hormonal imbalance, abnormal vessel fragility, or uterine abnormalities cause disrupted shedding and excessive endometrial bleeding

📌 Clinical Features
• Heavy menstrual bleeding requiring frequent pad/tampon changes
• Use of both pad & tampon
• Passage of large clots
• Prolonged bleeding >7 days
• Anaemia symptoms: fatigue, SOB, pallor
• Impact on daily life is a diagnostic clue
• Pain not always present – distinguish from dysmenorrhoea

📌 Differential Diagnoses
• Fibroids
• Endometrial polyps
• Endometriosis
• Malignancy
• DUB (diagnosis of exclusion)

📌 Investigations
🔹 Full Blood Count (FBC) – check for anaemia
🔹 Thyroid Function Tests – if suspected
🔹 PBAC (Pictorial Blood Loss Assessment Chart)
🔹 TVUS (Transvaginal Ultrasound) – assess endometrial thickness, fibroids, polyps
🔹 Endometrial Biopsy – >45 years, intermenstrual bleeding, failed treatment
🔹 Outpatient Hysteroscopy – if pathology suspected
🔹 Referral Indications: anaemia unresponsive to iron, suspected malignancy, abnormal pelvic findings

📌 Management
🩺 Medical (First-line)
• NSAIDs (mefenamic acid) – reduce prostaglandins
• Tranexamic acid – antifibrinolytic
• Hormonal:

• LNG-IUS (e.g., Mirena) – first-line if contraception acceptable

• COCP, long-acting progestins

• Norethisterone (short-term control)

🩻 Surgical (If medical fails / unsuitable)
• Endometrial ablation – uterus <10-week size
• Hysteroscopic myomectomy / UAE – for fibroids
• Hysterectomy – last resort if fertility not desired
⚠️ Hysterectomy NOT first-line for DUB
💉 Give anti-D if Rh-negative and surgical management is used

📌 Complications
• Iron-deficiency anaemia
• Reduced quality of life
• Psychological distress
• Potential fertility issues
• Surgery risks – bleeding, infection, DVT, menopause if ovaries removed

📌 Prognosis
• Good with proper investigation & treatment
• NICE: management should focus on improving QOL and aligning with patient preferences

📎 More MSRA Resources
📝 Revision Notes: https://www.passthemsra.com/topic/menorrhagia-heavy-menstrual-bleeding-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/menorrhagia-heavy-menstrual-bleeding-flashcards/
💬 Accordion Q&A: https://www.passthemsra.com/topic/menorrhagia-heavy-menstrual-bleeding-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/menorrhagia-heavy-menstrual-bleeding-rapid-quiz/
🎓 Course: https://www.passthemsra.com/courses/obstetrics-and-gynaecology-for-the-msra/

#MSRA #MSRARevision #MSRAMenorrhagia #MSRAFlashcards #MSRAQuiz #MSRAQANotes #MSRATextbook #ObstetricsAndGynaecology #HeavyMenstrualBleeding #GynaeMSRA #PALMCOEIN